NCT01706315 This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01706302 Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009 Status COMPLETED Phase N/A
NCT01706263 U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne Status COMPLETED Phase PHASE4
NCT01706224 Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals Status COMPLETED Phase N/A
NCT01706198 An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma Status COMPLETED Phase PHASE3
NCT01706185 Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer Status COMPLETED Phase N/A
NCT01702857 A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) Status COMPLETED Phase PHASE1
NCT01702519 A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers Status COMPLETED Phase PHASE1
NCT01702480 Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects Status COMPLETED Phase PHASE1
NCT01702467 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01702454 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345 Status COMPLETED Phase PHASE3
NCT01702428 Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age Status COMPLETED Phase PHASE3
NCT01702376 This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT01702350 A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study Status TERMINATED Phase PHASE1
NCT01702337 Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine Status COMPLETED Phase N/A
NCT01700010 Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer Status WITHDRAWN Phase PHASE2